Impact Analysis of miR-1253 on Lung Cancer Progression Through Targeted Regulation of ANXA3

References

• Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small cell lung cancer: multiple diseases. Rev Nat. 2014;14(8):535–546. doi:10.1038/nrc3775
   PubMed Web of Science ®Google Scholar
• Wood SL, Pernemalm M, Crosbie PA, Whetton AD. Role of tumor microenvironment in lung cancer metastasis and its relationship with potential therapeutic targets. Cancer Treatment. 2014;40(4):558–566. doi:10.1016/j.ctrv.2013.10.001
   Google Scholar
• Wu H, et al. Circulating exosomes microRNA-96 promotes cell proliferation, migration, and drug resistance by targeting LMO7. J Cell Molecules Medium. 2017;21(6):1228–1236. doi:10.1111/jcmm.13056
   PubMed Web of Science ®Google Scholar
• Sertaç Y, Sevtün S, Berker Ö, et al. Oxygen uptake efficiency slope and prediction of post-operative morbidity and mortality in patients with lung cancer. Lung. 2018;196:255–262. doi:10.1007/s00408-018-0085-y29349536
   PubMed Web of Science ®Google Scholar
• ElKhouly Aisha M, Youness RA, Gad MZ. MicroRNA-486-5p and microRNA-486-3p: multifaceted pleiotropic mediators in oncological and non-oncological conditions. Noncoding RNA Res. 2020;5(1):11–21. doi:10.1016/j.ncrna.2020.01.00131993547
   PubMed Web of Science ®Google Scholar
• Jianhua L, Junsu P, Yan J, et al. MiR-195-5p inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by targeting CEP55. Onco Targets Ther. 2019;12:11465–11474.31920335
   PubMed Web of Science ®Google Scholar
• Wenjing Q, Chengshun G, Li Z, et al. MiR-3196, a p53-responsive microRNA, functions as a tumor suppressor in hepatocellular carcinoma by targeting FOXP4. Am J Cancer Res. 2019;9(12):2665–2678.31911853
   PubMed Web of Science ®Google Scholar
• Lianghua S, Shanze Y, Luyuan H, et al. miR-330-3p promotes lung cancer cells invasion, migration, and metastasis by directly targeting hSOD2b. Biotechnol Appl Biochem. 2019;66(1):21–32. doi:10.1002/bab.169130192404
   PubMed Web of Science ®Google Scholar
• Yanbo C, Meng. Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2. Gene. 2018.
   Web of Science ®Google Scholar
• Gasparini P, Cascione L, Landi L, et al. microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers. Procedure Natl Coll Sci USA. 2015;112(48):14924–14929. doi:10.1073/pnas.1520329112
   PubMed Web of Science ®Google Scholar
• Tuomi JM, Voorbraak F, Jones DL, et al. The deviation of the Cq value observed by the quantitative probe-based PCR can be corrected by the estimated PCR efficiency value. Methods. 2010;50(4):313–322. doi:10.1016/j.ymeth.2010.02.00320138998
   PubMed Web of Science ®Google Scholar
• Byung-Seok K, Jelita C, Qing W, et al. Targeting ST2 expressing activated regulatory T cells in Kras-mutant lung cancer. Oncoimmunology. 2020;9:1682380. doi:10.1080/2162402X.2019.168238032002289
   PubMed Web of Science ®Google Scholar
• Harris CL, Toloza EM, Klapman JB, et al. Minimally invasive mediastinal staging of non-small cell lung cancer: focus on ultrasound-guided fine needle aspiration. Cancer Control. 2014;21:15–20. doi:10.1177/10732748140210010324357737
   PubMed Web of Science ®Google Scholar
• Yongbin C, Qinqin J, Xinghui L, et al. miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17. Cancer Sci. 2017;108:2366–2372. doi:10.1111/cas.1340128921827
   PubMed Web of Science ®Google Scholar
• Yanbo C, Meng G, Chong L, et al. Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2. Gene. 2019;686:37–42. doi:10.1016/j.gene.2018.10.08530389560
   PubMed Web of Science ®Google Scholar
• Herbst RS, Prager D, Hermann R, et al. TRIBUTE: a Phase III clinical trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel for advanced non-small cell lung cancer. J Clinical Oncol. 2005;23(25):5892–5899. doi:10.1200/JCO.2005.02.84016043829
   PubMed Web of Science ®Google Scholar
• Rota M, Pizzato M, La Vecchia C, et al. Efficacy of lung cancer screening appears to increase with prolonged intervention: results from the MILD trial and a meta-analysis. Ann Oncol. 2019;30:1040–1043. doi:10.1093/annonc/mdz14531046087
   PubMed Web of Science ®Google Scholar
• Zheng JH, Follis Viacava A, Kriwacki RW, Moldoveanu T. Discovery and controversy of BCL-2 protein-mediated apoptosis. FEBS J. 2016;283(14):2690–2700. doi:10.1111/febs.1352726411300
   PubMed Web of Science ®Google Scholar
• Fiandalo MV, Kyprianou N. Caspase control: protagonist of cancer cell apoptosis. Exp Oncol. 2012;34(3):165–175.23070001
   PubMedGoogle Scholar
• Lipeng H, Mangmang C, Jun P, et al. Circular RNA circNASP modulates the malignant behaviors in osteosarcoma via miR-1253/FOXF1 pathway. Biochem Biophys Res Commun. 2018;500(2):511–517. doi:10.1016/j.bbrc.2018.04.13129678578
   PubMed Web of Science ®Google Scholar
• Yi X, Yue Y, Ping G, et al. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294. Biochem Biophys Res Commun. 2019;509:138–142. doi:10.1016/j.bbrc.2018.12.08830591218
   PubMed Web of Science ®Google Scholar
• Saeed N, Elham B, Maleki Leili A, et al. Restoration of miR-193a-5p and miR-146 a-5p expression induces G1 arrest in colorectal cancer through targeting of MDM2/p53. Adv Pharm Bull. 2020;10(1):130–134. doi:10.15171/apb.2020.01732002372
   PubMed Web of Science ®Google Scholar
• Meiyue L, Yue Z, Jie Z, et al. MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A. Cell Death Dis. 2018;9(2):189. doi:10.1038/s41419-017-0218-x29415994
   PubMed Web of Science ®Google Scholar
• Perron B, Lewit-Bentley A, Geny B, Russo-Marie F. Is it possible to infer enzyme activity from the structural studies of Annexin III? J Biochem. 1997;272:11321–11326.
   Google Scholar
• Yang L, Men W-L, Yan K-M, et al. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3. Eur Rev Med Pharmacol Sci. 2018;22(15):4837–4845. doi:10.26355/eurrev_201808_1561930070320
   PubMed Web of Science ®Google Scholar
• Cai CH, Chen YT, Chang YH, et al. Systematic validation of tissue protein biomarker candidates related to bladder cancer in clinical urine samples. Oncotarget. 2018;9(56):30731–30747. doi:10.18632/oncotarget.2457830112103
   PubMedGoogle Scholar
• Wang K, Li J. ANXA3 overexpression is an independent prognostic indicator of gastric cancer, and its consumption inhibits cell proliferation and tumor growth. Oncotarget. 2016;7:86972–86984.27894078
   PubMedGoogle Scholar
• Limin W, Xueqin L, Yinghui R, et al. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA 3 in lung cancer cells. Cancer Sci. 2019;110(5):1609–1620. doi:10.1111/cas.1399830868675
   PubMed Web of Science ®Google Scholar
• Zhou T, Li Y, Yang L, et al. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells. Oncol Rep. 2016.
   Web of Science ®Google Scholar
• Tong M, Ma S. Secretory ANXA3 endows liver cancer cells with tumorigenic and self-renewal abilities and promotes HCC development. Cancer Res. 2015;75(15 Supplement):3946. doi:10.1158/0008-5472.CAN-15-003726249176
   PubMed Web of Science ®Google Scholar